{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:50:41Z","timestamp":1790682641071,"version":"4.1.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>We aimed to investigate the plasma levels of tryptophan (Trp) and its metabolites in patients with primary Sj\u00f6gren\u2019s syndrome (pSS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The study included 34 pSS patients and 42 healthy individuals, and serum Trp and kynurenine (Kyn) concentrations were measured by liquid chromatography with tandem mass spectrometry. Trp degradation was predicted using the ratio of Kyn and Trp concentrations (Kyn\/Trp).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In our study, the mean serum Trp concentration was found to be considerably lower in the pSS group than in the control group (P\u2005=\u2005.001). The levels of Kyn (P\u2005=\u2005.019) and the Kyn\/Trp ratio (P\u2005&amp;lt;\u2005.001) were significantly higher in the pSS group than in the control group. The Kyn\/Trp ratio was negatively correlated with C-reactive protein (r\u2005=\u2005\u22120.369, P\u2005=\u2005.032).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We found that Kyn pathway metabolism was altered in patients with pSS. This suggests that Trp metabolism may be closely linked to the disease pathogenesis of pSS.<\/jats:p><\/jats:sec>","DOI":"10.1093\/labmed\/lmac084","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T14:18:24Z","timestamp":1662128304000},"page":"166-172","source":"Crossref","is-referenced-by-count":13,"title":["Elevated Kynurenine Levels in Patients with Primary Sj\u00f6gren\u2019s Syndrome"],"prefix":"10.1093","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7219-1457","authenticated-orcid":false,"given":"Hakan","family":"Apayd\u0131n","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Ankara City Hospital , Ankara , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cemile","family":"Koca Bicer","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Ankara City Hospital, Ankara Y\u0131ld\u0131r\u0131m Beyaz\u0131t University , Ankara , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine","family":"Feyza Yurt","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Ankara City Hospital, Ankara Y\u0131ld\u0131r\u0131m Beyaz\u0131t University , Ankara , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhittin","family":"Abdulkadir Serdar","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Ac\u0131badem University , \u0130stanbul , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130smail","family":"Dogan","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Ankara City Hospital, Ankara Y\u0131ld\u0131r\u0131m Beyaz\u0131t University , Ankara , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukran","family":"Erten","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Ankara City Hospital, Ankara Y\u0131ld\u0131r\u0131m Beyaz\u0131t University , Ankara , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"issue":"1","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1542-0124(12)70289-6","article-title":"Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease","volume":"7","author":"Nguyen","year":"2009","journal-title":"Ocul Surf."},{"issue":"20","key":"2023030723490768400_","first-page":"354","article-title":"The diagnosis and treatment of Sj\u00f6gren\u2019s syndrome","volume":"114","author":"Stefanski","year":"2017","journal-title":"Dtsch \u00c4rztebl Int."},{"issue":"12","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00105-008-1671-3","article-title":"Sj\u00f6gren-Syndrom: Aktuelle Aspekte aus Rheumatologischer Sicht","volume":"59","author":"Tomiak","year":"2008","journal-title":"Hautarzt"},{"issue":"2","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/03009742.2014.931457","article-title":"Incident cases of primary Sj\u00f6gren\u2019s syndrome during a 5-year period in Stockholm County: a descriptive study of the patients and their characteristics","volume":"44","author":"Kvarnstr\u00f6m","year":"2015","journal-title":"Scand J Rheumatol."},{"issue":"4","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3899\/jrheum.100883","article-title":"Incidence and mortality of treated primary Sj\u00f6gren\u2019s syndrome in Taiwan: a population-based study","volume":"38","author":"Weng","year":"2011","journal-title":"J Rheumatol."},{"issue":"3","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/acr.22115","article-title":"Epidemiology of primary Sj\u00f6gren\u2019s syndrome in a French multiracial\/multiethnic area","volume":"66","author":"Maldini","year":"2014","journal-title":"Arthritis Care Res."},{"issue":"1","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2016.47","article-title":"Sj\u00f6gren syndrome","volume":"2","author":"Brito-Zeron","year":"2016","journal-title":"Nat Rev Dis Primers."},{"issue":"7","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.3390\/jcm9072299","article-title":"Current state of knowledge on primary Sj\u00f6gren\u2019s syndrome, an autoimmune exocrinopathy","volume":"9","author":"Parisis","year":"2020","journal-title":"J Clin Med."},{"issue":"2","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3390\/ijms22020658","article-title":"The Involvement of innate and adaptive immunity in the initiation and perpetuation of Sj\u00f6gren\u2019s syndrome","volume":"22","author":"Chivasso","year":"2021","journal-title":"Int J Mol Sci ."},{"issue":"2","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cyto.2014.02.009","article-title":"Early events in Sj\u00f6gren\u2019s syndrome pathogenesis: the importance of innate immunity in disease initiation","volume":"67","author":"Kramer","year":"2014","journal-title":"Cytokine."},{"issue":"7","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat Rev Neurosci."},{"issue":"4","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.20020121","article-title":"Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2, 3-dioxygenase","volume":"196","author":"Frumento","year":"2002","journal-title":"J Exp Med."},{"issue":"4","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1440-1711.2003.t01-1-01177.x","article-title":"Tryptophan and the immune response","volume":"81","author":"Moffett","year":"2003","journal-title":"Immunol Cell Biol."},{"issue":"3","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s10067-005-0056-6","article-title":"Tryptophan degradation increases with stage in patients with rheumatoid arthritis","volume":"25","author":"Schroecksnadel","year":"2006","journal-title":"Clin Rheumatol."},{"issue":"7","key":"2023030723490768400_","article-title":"Serum tryptophan and kynurenine concentrations as parameters for indoleamine 2, 3-dioxygenase activity in patients with endometrial, ovarian, and vulvar cancer","volume":"21","author":"de Jong","year":"2011","journal-title":"Int J Gynecol Cancer."},{"issue":"5","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/art.27403","article-title":"Regulation of myeloperoxidase-specific T cell responses during disease remission in antineutrophil cytoplasmic antibody\u2013associated vasculitis: the role of Treg cells and tryptophan degradation","volume":"62","author":"Chavele","year":"2010","journal-title":"Arthritis Rheumatol."},{"issue":"10","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/sj.cdd.4401073","article-title":"T cell apoptosis by tryptophan catabolism","volume":"9","author":"Fallarino","year":"2002","journal-title":"Cell Death Differ."},{"issue":"3","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar2205","article-title":"Inhibition of indoleamine 2, 3-dioxygenase-mediated tryptophan catabolism accelerates collagen-induced arthritis in mice","volume":"9","author":"Sz\u00e1nt\u00f3","year":"2007","journal-title":"Arthritis Res Ther."},{"issue":"5","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2005.03.013","article-title":"GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2, 3-dioxygenase","volume":"22","author":"Munn","year":"2005","journal-title":"Immunity."},{"issue":"9","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/ni.2077","article-title":"Indoleamine 2, 3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells","volume":"12","author":"Pallotta","year":"2011","journal-title":"Nat Immun."},{"issue":"9","key":"2023030723490768400_","first-page":"1935","article-title":"Increased degradation of tryptophan in blood of patients with rheumatoid arthritis","volume":"30","author":"Schroecksnadel","year":"2003","journal-title":"J Rheumatol."},{"issue":"5","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0171-2985(00)80079-0","article-title":"Enhanced tryptophan degradation in systemic lupus erythematosus","volume":"201","author":"Widner","year":"2000","journal-title":"Immunobiology."},{"key":"2023030723490768400_","doi-asserted-by":"crossref","DOI":"10.1515\/CCLM.1998.132","article-title":"Activated immune system in patients with Huntington\u2019s disease","volume-title":"Clin Chem Lab Med.","author":"Leblhuber","year":""},{"issue":"1","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann Rheum Dis."},{"issue":"6","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/ard.2009.110619","article-title":"EULAR Sj\u00f6gren\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sj\u00f6gren\u2019s syndrome","volume":"69","author":"Seror","year":"2010","journal-title":"Ann Rheum Dis."},{"issue":"6","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/ard.2010.143743","article-title":"EULAR Sj\u00f6gren\u2019s Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sj\u00f6gren\u2019s syndrome","volume":"70","author":"Seror","year":"2011","journal-title":"Ann Rheum Dis."},{"issue":"11","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.4155\/bio.13.74","article-title":"A simple LC-MS\/MS method for determination of kynurenine and tryptophan concentrations in human plasma from HIV-infected patients","volume":"5","author":"Huang","year":"2013","journal-title":"Bioanalysis."},{"issue":"3","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s11325-020-02250-7","article-title":"The evaluation of serum tryptophan and kynurenine levels in patients with obstructive sleep apnea syndrome","volume":"25","author":"\u0130riz","year":"2021","journal-title":"Sleep Breath."},{"issue":"1","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1600-065X.2010.00915.x","article-title":"Control of immune response by amino acid metabolism","volume":"236","author":"Grohmann","year":"2010","journal-title":"Immunol Rev."},{"issue":"2","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ni.3323","article-title":"Amino acid auxotrophy as a system of immunological control nodes","volume":"17","author":"Murray","year":"2016","journal-title":"Natur Immun."},{"issue":"12","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.biocel.2007.01.004","article-title":"Molecules in focus: indoleamine 2, 3-dioxygenase","volume":"39","author":"King","year":"2007","journal-title":"Int J Biochem Cell Biol."},{"issue":"6","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1042\/BST0361120","article-title":"Exploring the mechanism of tryptophan 2, 3-dioxygenase","volume":"36","author":"Thackray","year":"2008","journal-title":"Biochem Soc Trans."},{"key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"S2129","DOI":"10.4137\/IJTR.S2129","article-title":"L-tryptophan: basic metabolic functions, behavioral research and therapeutic indications.","volume":"2","author":"Richard","year":"2009","journal-title":"Int J Tryptophan Res"},{"issue":"11","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1096\/fasebj.5.11.1907934","article-title":"Relationship between interferon-\u03b3, indoleamine 2, 3-dioxygenase, and tryptophan catabolism","volume":"5","author":"Taylor","year":"1991","journal-title":"FASEB J."},{"issue":"1","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2249.2005.02889.x","article-title":"Mechanisms dependent on tryptophan catabolism regulate immune responses in primary Sj\u00f6gren\u2019s syndrome","volume":"142","author":"Pertovaara","year":"2005","journal-title":"Clin Exp Immunol."},{"issue":"3","key":"2023030723490768400_","first-page":"290","article-title":"Kynurenines pathway biomarkers for primary Sjogren\u2019s syndrome","volume":"36","author":"Valim","year":"2018","journal-title":"Clin Exp Rheumatol."},{"issue":"7","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"e0159384","DOI":"10.1371\/journal.pone.0159384","article-title":"Metabolic profiling of systemic lupus erythematosus and comparison with primary Sj\u00f6gren\u2019s syndrome and systemic sclerosis","volume":"11","author":"Bengtsson","year":"2016","journal-title":"PLoS One."},{"issue":"5","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1172\/JCI106043","article-title":"Serum kynurenine in rheumatoid arthritis","volume":"48","author":"Spiera","year":"1969","journal-title":"J Clin Investig."},{"issue":"1","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/1547691X.2017.1377323","article-title":"Expression of aryl hydrocarbon receptor, inflammatory cytokines, and incidence of rheumatoid arthritis in Vietnamese dioxin-exposed people","volume":"14","author":"Nguyen","year":"2017","journal-title":"J Immunotoxicol."},{"key":"2023030723490768400_","first-page":"29","article-title":"Aryl hydrocarbon receptor antagonism and its role in rheumatoid arthritis","volume":"7","author":"Nguyen","year":"2015","journal-title":"J Exp Pharmacol."},{"issue":"6","key":"2023030723490768400_","first-page":"67","article-title":"Exploitation of the IDO pathway in the therapy of rheumatoid arthritis","volume":"21","author":"Ro","year":"2013","journal-title":"Int J Tryptophan Res."},{"key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4615-0135-0_32","article-title":"Kynurenine and neopterin levels in patients with rheumatoid arthritis and osteoporosis during drug treatment","author":"Forrest","year":"2003","journal-title":"Developments in Tryptophan and Serotonin Metabolism."},{"issue":"1","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"e000254","DOI":"10.1136\/lupus-2017-000254","article-title":"Kynurenine pathway is altered in patients with SLE and associated with severe fatigue","volume":"5","author":"\u00c5kesson","year":"2018","journal-title":"Lupus Sci Med."},{"key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"108018","DOI":"10.1016\/j.intimp.2021.108018","article-title":"Altered kynurenine pathway metabolism in patients with ankylosing spondylitis","volume":"99","author":"Onmaz","year":"2021","journal-title":"Int Immunopharmacol."},{"issue":"7","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00296-017-3715-4","article-title":"Development of new extra-glandular manifestations or associated auto-immune diseases after establishing the diagnosis of primary Sj\u00f6gren\u2019s syndrome","volume":"37","author":"Ter Borg","year":"2017","journal-title":"Rheumatol Int."},{"key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.clim.2018.12.009","article-title":"Elevated kynurenine levels in diffuse cutaneous and anti-RNA polymerase III positive systemic sclerosis","volume":"199","author":"Campochiaro","year":"2019","journal-title":"Clin Immunol."},{"key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.neuropharm.2015.11.015","article-title":"Tryptophan availability for kynurenine pathway metabolism across the life span: control mechanisms and focus on aging, exercise, diet and nutritional supplements","volume":"112","author":"Badawy","year":"2017","journal-title":"Neuropharmacology."},{"issue":"94","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijpsycho.2014.08.898","article-title":"Excessive brain tryptophan and kynurenic acid lead to abnormal social behavior in central fatigue induced by chronic sleep disorder","volume":"2","author":"Yamashita","year":"2014","journal-title":"Int J Psychophysiol."},{"issue":"5","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00726-010-0787-9","article-title":"Kynurenine metabolism in health and disease","volume":"41","author":"Kolodziej","year":"2011","journal-title":"Amino Acids."},{"key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"110820","DOI":"10.1016\/j.exger.2019.110820","article-title":"IDO activation, inflammation and musculoskeletal disease","volume":"131","author":"Ogbechi","year":"2020","journal-title":"Exp Gerontol."},{"issue":"1","key":"2023030723490768400_","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/acr.22720","article-title":"Fatigue in primary Sj\u00f6gren\u2019s syndrome: clinical, laboratory, psychometric, and biologic associations","volume":"68","author":"Karageorgas","year":"2016","journal-title":"Arthritis Care Res."}],"container-title":["Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/54\/2\/166\/49446456\/lmac084.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/54\/2\/166\/49446456\/lmac084.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T03:55:42Z","timestamp":1700970942000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/labmed\/article\/54\/2\/166\/6687154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":51,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,9,2]]},"published-print":{"date-parts":[[2023,3,7]]}},"URL":"https:\/\/doi.org\/10.1093\/labmed\/lmac084","relation":{},"ISSN":["0007-5027","1943-7730"],"issn-type":[{"value":"0007-5027","type":"print"},{"value":"1943-7730","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3,1]]},"published":{"date-parts":[[2022,9,2]]}}}